[1]施秉银.甲状腺结节:从迷茫到清晰[J].国际内分泌代谢杂志,2022,42(02):93-95.[doi:10.3760/cma.j.cn121383-20210208-02005]
 Shi Bingyin..Thyroid nodule: from confusion to clarity[J].International Journal of Endocrinology and Metabolism,2022,42(02):93-95.[doi:10.3760/cma.j.cn121383-20210208-02005]
点击复制

甲状腺结节:从迷茫到清晰()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
42
期数:
2022年02期
页码:
93-95
栏目:
述评
出版日期:
2022-03-20

文章信息/Info

Title:
Thyroid nodule: from confusion to clarity
作者:
施秉银
西安交通大学第一附属医院内分泌科 710061
Author(s):
Shi Bingyin.
Department of Endocrinology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
DOI:
10.3760/cma.j.cn121383-20210208-02005

参考文献/References:

[1] Beano AM,Zmaili MA,Zayed AA.Thyroid nodules[J].N Engl J Med,2016,374(13):1294.DOI:10.1056/NEJMc1600493.
[2] Guth S,Theune U,Aberle J,et al.Very high prevalence of thyroid nodules detected by high frequency(13 MHz)ultrasound examination[J].Eur J Clin Invest,2009,39(8):699-706.DOI:10.1111/j.1365-2362.2009.02162.x.
[3] Li Y,Jin C,Li J,et al.Prevalence of thyroid nodules in China:a health examination cohort-based study[J].Front Endocrinol(Lausanne),2021,12:676144.DOI:10.3389/fendo.2021.676144.
[4] Ahn HS,Kim HJ,Welch HG.Korea's thyroid-cancer "epidemic"--screening and overdiagnosis[J].N Engl J Med,2014,371(19):1765-1767.DOI:10.1056/NEJMp1409841.
[5] Jegerlehner S,Bulliard JL,Aujesky D,et al.Overdiagnosis and overtreatment of thyroid cancer:a population-based temporal trend study[J].PLoS One,2017,12(6):e0179387.DOI:10.1371/journal.pone.0179387.
[6] Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.DOI:10.3322/caac.21338.
[7] Welch HG,Black WC.Overdiagnosis in cancer[J].J Natl Cancer Inst,2010,102(9):605-613.DOI:10.1093/jnci/djq099.
[8] VanderLaan WP.The occurrence of carcinoma of the thyroid gland in autopsy material[J].N Engl J Med,1947,237(7):221.DOI:10.1056/NEJM 194708142370703.
[9] Harach HR,Franssila KO,Wasenius VM.Occult papillary carcinoma of the thyroid.A "normal" finding in Finland.A systematic autopsy study[J].Cancer,1985,56(3):531-538.DOI:10.1002/1097-0142(19850801)56:3<531::aid-cncr2820560321>3.0.co; 2-3.
[10] Furuya-Kanamori L,Bell KJL,Clark J,et al.Prevalence of differentiated thyroid cancer in autopsy studies over six decades:a meta-analysis[J].J Clin Oncol,2016,34(30):3672-3679.DOI:10.1200/JCO.2016.67.7419.
[11] Lubitz CC,Kong CY,McMahon PM,et al.Annual financial impact of well-differentiated thyroid cancer care in the United States[J].Cancer,2014,120(9):1345-1352.DOI:10.1002/cncr.28562.
[12] Haugen BR,Alexander EK,Bible KC,et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer:the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J].Thyroid,2016,26(1):1-133.DOI:10.1089/thy.2015.0020.
[13] Liu Y,Wang Y,Zhao K,et al.Lymph node metastasis in young and middle-aged papillary thyroid carcinoma patients:a SEER-based cohort study[J].BMC Cancer,2020,20(1):181.DOI:10.1186/s12885-020-6675-0.
[14] Nikiforov YE,Seethala RR,Tallini G,et al.Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma:a paradigm shift to reduce overtreatment of indolent tumors[J].JAMA Oncol,2016,2(8):1023-1029.DOI:10.1001/jamaoncol.2016.0386.

备注/Memo

备注/Memo:
通信作者:施秉银,Email:shibingy@126.com
基金项目:国家重点研发计划(2018YFC1311500):西北地区慢病防控科技综合示范研究
更新日期/Last Update: 2022-04-20